MedPath

Measuring and Improving Medication Adherence in Kidney Transplant Patients

Not Applicable
Completed
Conditions
Kidney Transplant Recipients
Interventions
Behavioral: Standard Care
Behavioral: Cognitive-behavioral adherence promotion program
Registration Number
NCT02639949
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Brief Summary

Nonadherence to medication is a major obstacle to successful treatment of renal transplant patients. This study has two primary aims. The first is to test whether a culturally sensitive cognitive-behavioral adherence promotion program could significantly improve medication adherence to tacrolimus prescription. Participants will be randomly assigned to either group CBT or to standard care. The second aim is to pilot a novel strategy of adherence measurement - unannounced telephone pill counts, which has been shown to be a valid and reliable means to measure medication adherence in other patient populations. Participants will be recruited from waiting area of the kidney transplant clinic at SUNY Downstate Medical Center in Brooklyn, NY. Three unannounced telephone pill counts will be conducted prior to start of the intervention in order to establish baseline adherence and three pill counts will be conducted post-intervention. Tacrolimus trough concentration levels will also be collected as an additional biological measure of adherence.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • current prescription of tacrolimus less than 98% adherence to medication prescription as determined by three baseline pill counts
Exclusion Criteria
  • lack of telephone to complete pill counts lack of English proficiency to participate in adherence promotion sessions

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Standard CareStandard Care-
Group CBTCognitive-behavioral adherence promotion program-
Primary Outcome Measures
NameTimeMethod
Adherence as measured by unannounced telephone pill count3 months
Secondary Outcome Measures
NameTimeMethod
degree of agreement between pill count data and laboratory tacrolimus levels3 months
© Copyright 2025. All Rights Reserved by MedPath